P
Prestige Biologics Co Ltd
KOSDAQ:334970
Prestige Biologics Co Ltd
KOSDAQ:334970
Price:
2 315
KRW
0.22%
Market Closed
Market Cap:
₩180B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Prestige Biologics Co Ltd
KOSDAQ:334970
|
KR |
|
K
|
Krosaki Harima Corp
TSE:5352
|
JP |
|
SICO Saudi REIT Fund
SAU:4337
|
SA |
|
FIH Mobile Ltd
F:FW3
|
TW |
|
Argan Inc
NYSE:AGX
|
US |
|
BT Group PLC
LSE:BT.A
|
UK |
|
Samwha Electric Co Ltd
KRX:009470
|
KR |
|
P
|
Perseus Mining Ltd
LSE:0TXW
|
AU |
|
Hycroft Mining Holding Corporation
NASDAQ:HYMC
|
US |
Balance Sheet
Balance Sheet Decomposition
Prestige Biologics Co Ltd
Prestige Biologics Co Ltd
Balance Sheet Decomposition is not available for
Prestige Biologics Co Ltd
Prestige Biologics Co Ltd
Balance Sheet
Prestige Biologics Co Ltd
Prestige Biologics Co Ltd
Currency: KRW
| Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
45 435
|
29 507
|
1 582
|
|
| Cash |
45 435
|
29 507
|
1 582
|
|
| Total Receivables |
2 073
|
1 654
|
4 963
|
|
| Accounts Receivables |
1 432
|
599
|
438
|
|
| Other Receivables |
641
|
1 055
|
4 525
|
|
| Inventory |
6 833
|
17 805
|
26 909
|
|
| Other Current Assets |
15 901
|
6 669
|
7 395
|
|
| Total Current Assets |
70 242
|
55 636
|
40 848
|
|
| PP&E Net |
234 435
|
233 052
|
228 406
|
|
| PP&E Gross |
234 435
|
233 052
|
228 406
|
|
| Accumulated Depreciation |
21 096
|
32 075
|
44 931
|
|
| Intangible Assets |
1 047
|
677
|
1 032
|
|
| Other Long-Term Assets |
29
|
50
|
0
|
|
| Total Assets |
305 753
N/A
|
289 414
-5%
|
270 286
-7%
|
|
| Liabilities | ||||
| Accounts Payable |
587
|
3 048
|
7 237
|
|
| Accrued Liabilities |
3 149
|
6 636
|
505
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
43 163
|
47 617
|
58 795
|
|
| Other Current Liabilities |
42 198
|
35 005
|
35 880
|
|
| Total Current Liabilities |
89 098
|
92 306
|
102 417
|
|
| Long-Term Debt |
116 853
|
125 426
|
32 666
|
|
| Total Liabilities |
205 950
N/A
|
217 732
+6%
|
135 083
-38%
|
|
| Equity | ||||
| Common Stock |
30 554
|
30 751
|
38 876
|
|
| Retained Earnings |
189 063
|
218 437
|
245 907
|
|
| Additional Paid In Capital |
256 059
|
257 963
|
341 501
|
|
| Other Equity |
2 253
|
1 406
|
733
|
|
| Total Equity |
99 803
N/A
|
71 682
-28%
|
135 203
+89%
|
|
| Total Liabilities & Equity |
305 753
N/A
|
289 414
-5%
|
270 286
-7%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
61
|
62
|
78
|
|
Switch to:
Switch to:
See Also
Discover More
